Europe – EMA recommendation paper: Safety, data integrity key to decentralized trial conduct

The European Medicines Agency (EMA), European Commission (EC), and Heads of Medicines Agencies (HMA) recently acknowledged the growing role of decentralized elements in the...
Ajovy bags NICE approval

UK – Bristol Myers Squibb’s Opdivo recommended by NICE for rare gastroesophageal cancers

Specifically, NICE’s recommendation is extended to patients with untreated HER2-negative, advanced or metastatic gastric, gastro-oesophageal junction or oesophageal adenocarcinoma if the tumours express PD-L1...
WHO drafts guidance for pharma supply chain tracking

International – WHO proposes updated excipient GMPs in wake of contaminated cough syrup

The World Health Organization (WHO) recently proposed updated guidance to assist pharmaceutical manufacturers in assessing the quality of excipients after child deaths were reported...
NICE ‘OK’ for Lynparza

UK – AstraZeneca’s heart failure treatment recommended by NICE for expanded use

Forxiga, sold as Farxiga in certain markets, has previously been recommended by NICE as a treatment option for HF patients with reduced ejection fraction...

USA – FDA finalizes guidance on considerations for evaluating drug’s benefits and risks

The US Food and Drug Administration (FDA) has finalized guidance that clarifies how the benefits and risks of a drug or biologic factored into...
Guidance Agenda: Guidance Documents CBER is Planning to Publish During Calendar Year 2020

USA – CBER chief on remote work, CRISPR-Cas9, and rare disease gene therapy accelerated...

The use of CRISPR-Cas9 gene editing technology has potential to transform the field of gene therapy through its simple and cost-effective delivery mechanism, said...

UK – Digital cognitive behaviour therapies recommended by NICE across the NHS

The National Institute for Health and Care Excellence (NICE) has conditionally recommended digital cognitive behaviour therapies (CBT) for use in the NHS. It is...

Europe – EMA recommends approval of VidPrevtyn Beta as a COVID 19 booster vaccine

EMA’s human medicines committee (CHMP) has recommended authorising the COVID-19 vaccine VidPrevtyn Beta as a booster in adults previously vaccinated with an mRNA or...

International – ICH advances guidelines on selective reporting of safety data, viral safety

The International Council for Harmonisation (ICH) recently announced the adoption of its E19 guideline, which outlines a risk-based approach for collecting safety data for...

USA – Industry experts tout potential for master protocols in pediatric clinical trials

Using master protocols in pediatric clinical trials could speed the development of drugs for pediatric indications that already have development programs for adults, according...